The funding includes a $150,000 loan from the state of Wisconsin and investments from several private sources in Wisconsin.
In addition, the company announced it is moving its operations to Madison, Wis.
Read the release about Flex Biomedical.
Flex Biomedical Raises Nearly $1M to Further Develop Polymer to Treat Osteoarthritis
Flex Biomedical, a privately-held orthopedics company in Boston, has raised $985,000 to advance its lead product, the Flex Polymer, a synthetic polymer to treat osteoarthritis.
Next Up in Uncategorized
-
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
-
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
-
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.